Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Discover world index performance examples to understand how major benchmarks behave across regions and periods. This primer helps investors compare scales and draw quick insights.
21,743 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Bitmine Immersion Technologies moves toward a 5% ETH stake, threatening to redefine Ethereum's staking economics whil...
Braze beat Q4 expectations with $205.17 million in revenue and 27.9% annual growth, as analysts weigh the AI-driven g...
Rockwell Medical is a niche player in renal care. This analysis breaks down rockwell medical (rmti) earnings, what th...
Scotiabank boosted Cameco's price target to $175 as a global push for nuclear power gains traction and a new supply d...
A practical, plain‑language breakdown of Navigator NVGS's Q1 2026 earnings trajectory. Learn what drives revenue, how...
When a company director trims a stake, investors ask: what does it mean for the stock? This guide walks you through h...
Smart investors look beyond the loud headlines. This guide explains how overlooked stocks soar 2026 by spotting catal...
Markets sold off Monday as U.S.-Iran ceasefire talks stalled, sending oil higher and pulling down stock futures. Anal...
The Roundhill Memory ETF fell roughly 5% in early trading after a dramatic six-week breakout. Analysts say profit-tak...
A big jump in ezcorp stock 130% has investors buzzing. This piece explains what happened, why an investor sold millio...
May presents a rare chance to own a glorious growth stock hand with enduring momentum. This guide breaks down why one...